09-05-2025
Analysts Offer Insights on Healthcare Companies: Definitive Healthcare Corp (DH) and Silence Therapeutics (SLN)
There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Definitive Healthcare Corp (DH – Research Report) and Silence Therapeutics (SLN – Research Report) with bullish sentiments.
Protect Your Portfolio Against Market Uncertainty
Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Definitive Healthcare Corp (DH)
In a report released today, Ryan Daniels from William Blair maintained a Buy rating on Definitive Healthcare Corp. The company's shares closed last Thursday at $2.81, close to its 52-week low of $2.55.
According to Daniels is a 4-star analyst with an average return of 7.7% and a 49.6% success rate. Daniels covers the Healthcare sector, focusing on stocks such as Lifestance Health Group, Pediatrix Medical Group, and Alignment Healthcare.
The word on The Street in general, suggests a Hold analyst consensus rating for Definitive Healthcare Corp with a $4.57 average price target.
Silence Therapeutics (SLN)
William Blair analyst Myles Minter maintained a Buy rating on Silence Therapeutics today. The company's shares closed last Thursday at $3.56, close to its 52-week low of $3.19.
According to Minter is a 4-star analyst with an average return of 5.0% and a 48.6% success rate. Minter covers the Healthcare sector, focusing on stocks such as CAMP4 Therapeutics Corporation, Neumora Therapeutics, Inc., and Entrada Therapeutics Inc.
